Our latest insights

What We're Thinking

Trends Report 2024

After the positive reception to our inaugural Trends Report, we’re excited to introduce our 2024 Trends Report. Beyond reporting on what we learned, we have also added commentary throughout based on what we have seen transpire in life sciences talent this past year and how we expect it to evolve in the year to come.

Read More

The Mix Tape | Special Edition – Cell and Gene Tx Journey to Commercialization: Drug Approval & Post-Approval

In part 2 of our Special Edition Series – Cell and Gene Tx Journey to Commercialization – Abbey Jenkins (CEO, Gamida Cell) and Izzy Tyszler (VP of Commercial, Zevra Therapeutics) join ADVI Health’s Director of Health Policy and Reimbursement, Alicia Silver, to discuss commercialization of gene and cell therapies. Abbey and Izzy share their key learnings from past experiences leading commercial teams, including advice on how best to prepare for commercialization.

Read More

Going Through Changes: Transition Coaching for Leaders

Periods of organizational or personal change demand executives and other corporate leaders to guide themselves and their teams through unpredictable challenges. During these times of instability, transitional coaching gives leaders the tools and clarity to navigate confidently through the turbulence.

Read More

The Mix Tape | Special Edition – Cell and Gene Tx Journey to Commercialization: Drug Development and Manufacturing

Welcome back to The Mix Tape! In this 2-part special edition, Mix Talent teamed up with ADVI Health to bring together women leaders in Cell and Gene Therapy to discuss the journey from manufacturing to commercialization. This series will feature insights from our incredible guests on their learnings from past experiences, tips and tricks, and anticipated trends in biotech.

Read More

My Dad’s 5 Keys to Success

Mix Talent President Mickey Shimp shares the simple-but-effective advice his dad, Paul Shimp, gave him about being successful – and how that advice is put into action by the Mix O/S.

Read More

Mix Talent is recognizing Rare Disease Day 2024 by celebrating rare heroes from across the country whose initiative, advocacy, and perseverance are making a difference in the lives of others.

After the positive reception to our inaugural Trends Report, we’re excited to introduce our 2024 Trends Report. Beyond reporting on what we learned, we have also added commentary throughout based on what we have seen transpire in life sciences talent this past year and how we expect it to evolve in the year to come.

In part 2 of our Special Edition Series - Cell and Gene Tx Journey to Commercialization - Abbey Jenkins (CEO, Gamida Cell) and Izzy Tyszler (VP of Commercial, Zevra Therapeutics) join ADVI Health’s Director of Health Policy and Reimbursement, Alicia Silver, to discuss commercialization of gene and cell therapies. Abbey and Izzy share their key learnings from past experiences leading commercial teams, including advice on how best to prepare for commercialization.

Periods of organizational or personal change demand executives and other corporate leaders to guide themselves and their teams through unpredictable challenges. During these times of instability, transitional coaching gives leaders the tools and clarity to navigate confidently through the turbulence.

Welcome back to The Mix Tape! In this 2-part special edition, Mix Talent teamed up with ADVI Health to bring together women leaders in Cell and Gene Therapy to discuss the journey from manufacturing to commercialization. This series will feature insights from our incredible guests on their learnings from past experiences, tips and tricks, and anticipated trends in biotech.

Mix Talent President Mickey Shimp shares the simple-but-effective advice his dad, Paul Shimp, gave him about being successful – and how that advice is put into action by the Mix O/S.

Scroll to Top

Let's Mix!

If you’d like to learn more about what we do, get in touch and discover how we can help you make it happen.

10 Talent Trends
for the Life Sciences in 2024

Stay on top of a shifting life sciences landscape